Medicine for treating contagious ecthyma

Abstract

The invention discloses a medicine for treating contagious ecthyma. Each milliliter of the medicine comprises: 0.025-0.028g of ribavirin, 0.0035-0.004g of ceftiofur sodium, glycerin with a volume concentration of 2%-2.5%, and the balance normal saline. The medicine of the invention can rapidly inhibit replication of a contagious ecthyma virus, and prevent an aphthous ulcer surface from developing into secondary bacterial infections. The medicine provided in the invention has the advantages of uneasy volatilization, sufficient sources of medicine components, low price, convenient use, good treatment effect, cure rate up to 75%, lamb mortality declined by 5%, condition improvement rate of 90%, and no harm to breeders.

Description

technical field [0001] The invention belongs to the technical field of animal medicine, in particular to a medicine for treating aphthous ulcer. Background technique [0002] In the breeding industry, it is very common for livestock to have skin lesions, and the mortality rate of some skin lesions is relatively high, such as aphthous ulcer disease, aphthous aphthous ulcer is a zoonotic infectious disease caused by aphthous oral ulcer virus of the parapoxvirus genus. If the secondary infection causes a higher mortality rate of sheep (especially lambs), the data show that the mortality rate of mild canker sores (ie lip type) is about 10%, and moderate canker sore disease (ie lip+eyelid type) ) has a mortality rate of 20%-30%, and the mortality rate of severe aphthous disease (ie lip+hard palate or gingiva type) is 60%-80%. Simultaneously, sheep aphthous disease also seriously threatens the healthy of breeder. [0003] At present, the common medicines for the treatment of aph...

AI Technical Summary

Problems solved by technology

[0003] At present, the common medicines for the treatment of aphthous ulcers are conventional disinfection medicines such as purple syrup and iodine glycerin, and the treatment effect is not satisfactory.